![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Dipexium Announces Top-line Data from OneStep Phase III Trials
Dipexium Announces Top-line Data from OneStep Phase III Trials
Dipexium Pharmaceuticals announced that the OneStep-1 and OneStep-2 Phase 3 clinical trials of Locilex (pexiganan cream 0.8%) in patients with mild infections of diabetic foot ulcers (Mild DFI) did not meet the primary clinical endpoint of superiority versus a cream vehicle plus standardized wound care.
The clinical trials conducted simultaneously enrolled a total of 389 patients at 59 separate centers in the U.S.
Upcoming Events
-
21Oct